Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
Peripheral T cell lymphoma (PTCL) represents a group of heterogeneous hematological
malignancies, which are notoriously challenging to treat and outcomes are typically poor …
malignancies, which are notoriously challenging to treat and outcomes are typically poor …
Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma
X Zong, Z Yang, J Zhou, Z Jin, D Wu - Frontiers in Immunology, 2024 - frontiersin.org
Background Angioimmunoblastic T-cell lymphoma (AITL) is known for its unfavorable
survival prognosis. Chidamide has shown efficacy in relapsed/refractory AITL, but its efficacy …
survival prognosis. Chidamide has shown efficacy in relapsed/refractory AITL, but its efficacy …